✦ LIBER ✦

147 Phase II studies of a 60 mg/m2 dose of docetaxel in patients with non-small cell lung cancer

✍ Scribed by Hiraki, S.; Watanabe, K.; Furuse, K.; Kudo, S.; Ohnoshi, T.; Niitani, H.

Book ID: 121992437
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 157 KB
Volume: 18
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(97)89426-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of low-dose docetaxel (

A phase II trial of low-dose docetaxel (DCT) 60 mg/m2 in platinum-pretreated advanced non-small cell lung cancer (NSCLC)

✍ Kusaba, H; Nakamura, Y; Kunitoh, H; Sekine, I; Kubota, K; Tamura, T; Shinkai, T; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Phase II trial of a 75-mg/m2 dose of doc

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

✍ Vincent A. Miller; James R. Rigas; Prudence A. Francis; Stefan C. Grant; Katheri 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

## Background. A prior Phase I1 study of a 100-mg/m2 dose of docetaxel conducted at the Memorial Sloan-Kettering Cancer Center (New York, NY) demonstrated a 38% response rate with grade 3 or 4 neutropenia in 76% of the patients and a grade 2 or greater rash or infusionrelated reaction in 41% and 3

Phase II trial of a 75-mg/m2 dose of doc

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Japanese experience with second-line che

Japanese experience with second-line chemotherapy with low-dose (60 mg/m2) docetaxel in patients with advanced non-small-cell lung cancer

✍ Toru Mukohara; Koji Takeda; Masaki Miyazaki; Nobuhide Takifuji; Kazuhiko Terakaw 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 79 KB

Consecutive phase II trials of docetaxel

Consecutive phase II trials of docetaxel (taxotere®) 100 MG/M2 and 75 MG/M2 with prednisone in patients with stage IIIB and IV non-small cell lung cancer

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 145 KB

A phase II study of docetaxel plus nedap

A phase II study of docetaxel plus nedaplatin in patients with metastatic non-small-cell lung cancer

✍ Koji Teramoto, Yoshikuni Asada, Yoshitomo Ozaki… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 222 KB